Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity
Title
Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity
Creator
Walker P; Watanabe S; Lawlor P; Hanson J; Pereira J; Bruera E
Identifier
Publisher
Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / Esmo
Date
1997
Subject
Female; Humans; Male; Aged; Middle Aged; 80 and over; Injections; Neoplasms/complications; Subcutaneous; Clodronate; Hypercalcemia/drug therapy; Clodronic Acid/administration & dosage/adverse effects
Description
The logistics of administering intravenous bisphosphonates may be problematic in the care of advanced cancer patients, especially in the home setting. Hypodermoclysis is a convenient method of administering fluid via subcutaneous infusion, presently used in the domiciliary setting. Results of the administration of clodronate via this route are reported.
1997
Rights
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
Journal Article
Citation List Month
Backlog
URL Address
Citation
Walker P; Watanabe S; Lawlor P; Hanson J; Pereira J; Bruera E, “Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity,” Pediatric Palliative Care Library, accessed April 29, 2024, https://pedpalascnetlibrary.omeka.net/items/show/12172.